MedTrace Logo

A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section

NCT02741219 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2021-05-07

No results posted yet for this study

Summary

The purpose of this multicenter study is to evaluate the effectiveness and safety of dexmedetomidine combined with sufentanil for patient-controlled analgesia after caesarean section

Conditions

  • Postoperative Pain

Interventions

DRUG

Normal saline

Control Group receives normal saline bolus after delivery

DRUG

Dexmedetomidine

Dex Group receives dexmedetomidine bolus 0.5mcg/kg after delivery

DRUG

Sufentanil

sufentanil PCA after surgery

DRUG

Sufentanil and dexmedetomidine

sufentanil combined with dexmedetomidine PCA after surgery

Sponsors & Collaborators

  • Obstetrics & Gynecology Hospital of Fudan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02741219 on ClinicalTrials.gov